DuPre C T, Fincher R M
Medical College of Georgia School of Medicine, Department of Medicine, Augusta 30912.
Am J Med Sci. 1992 Apr;303(4):241-4. doi: 10.1097/00000441-199204000-00006.
Although cavernous hemangioma is the most common benign tumor of the liver, controversy persists regarding diagnosis and management of these lesions. With the development of multiple noninvasive modalities to visualize the liver, hepatic cavernous hemangiomas are recognized with increased frequency. The authors report the unusual case of a post-menopausal woman on no exogenous estrogen therapy who had a cavernous hemangioma that remained stable for approximately 10 years before dramatically increasing in size. This patient illustrates the vague symptoms associated with cavernous hemangiomas and the unpredictability of growth. Although estrogens have been reported trophic, this patient had no exogenous or endogenous estrogen supply, yet her lesion reached massive proportions. Modalities necessary to assure accurate diagnosis and factors influential in management are discussed.
尽管海绵状血管瘤是肝脏最常见的良性肿瘤，但关于这些病变的诊断和管理仍存在争议。随着多种用于肝脏可视化的非侵入性检查方法的发展，肝海绵状血管瘤的发现频率有所增加。作者报告了一例绝经后未接受外源性雌激素治疗的女性病例，其患有海绵状血管瘤，在大小急剧增加之前保持稳定约10年。该患者说明了与海绵状血管瘤相关的模糊症状以及生长的不可预测性。尽管有报道称雌激素具有营养作用，但该患者既无外源性也无内源性雌激素供应，但其病变却发展到很大规模。本文讨论了确保准确诊断所需的检查方法以及对治疗有影响的因素。
